U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533136) titled 'Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax' on April 09.
Brief Summary: This study is to conduct a clinical trial of tafenoquine combinations to compare the rates of therapeutic efficacy of dihydroartemisinin-piperaquine or artemether-lumefantrine with tafenoquine to chloroquine plus tafenoquine in preventing recurrence of Plasmodium vivax over a 6-month period in adult subjects with uncomplicated P. vivax infection living in Thailand.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Uncomplicated P. Vivax Mono-infection
Intervention:
DRUG: Tafenoquine (TQ)
Tafenoquine 150 m...